发达发达
voted
$NVIDIA (NVDA.US)$ bulls are pouring millions of dollars in the options market a day after the short sale volume on the stock climbed by almost 57%.
Unusual option trades tracked by moomoo showed 17 big bullish transactions were posted in the first three hours after the market opened Thursday. The biggest of them involved an active buyer paying a $5.86 million premium for call options that give the holder the right to buy...
Unusual option trades tracked by moomoo showed 17 big bullish transactions were posted in the first three hours after the market opened Thursday. The biggest of them involved an active buyer paying a $5.86 million premium for call options that give the holder the right to buy...
52
19
发达发达
liked
The much-anticipated rate cut decision has finally arrived, with the Federal Reserve announcing a 50 basis point rate cut! At this pivotal moment, investors need to have a deeper understanding of the background and impact of rate cuts.
Since March 2022, in a bid to curb inflation, the Fed has hiked rates 11 times, bringing it to the current range of 5.25%-5.50%. Now that inflation is under control, the calls for a rate cut are growin...
Since March 2022, in a bid to curb inflation, the Fed has hiked rates 11 times, bringing it to the current range of 5.25%-5.50%. Now that inflation is under control, the calls for a rate cut are growin...
+4
401
176
发达发达
commented on
$AIM ImmunoTech (AIM.US)$
AIM ImmunoTech Reports Positive Preliminary Data in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer
AIM ImmunoTech (NYSE American: AIM) reported positive preliminary data from its Phase 1b/2 study of Ampligen and Imfinzi combination therapy for late-stage pancreatic cancer. The study showed stable disease in two out of three patients at 6 months in the first subject cohort. The combination therapy was generally wel...
AIM ImmunoTech Reports Positive Preliminary Data in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer
AIM ImmunoTech (NYSE American: AIM) reported positive preliminary data from its Phase 1b/2 study of Ampligen and Imfinzi combination therapy for late-stage pancreatic cancer. The study showed stable disease in two out of three patients at 6 months in the first subject cohort. The combination therapy was generally wel...
1
1
发达发达
commented on
$Galecto (GLTO.US)$ Galecto Has Regained Compliance With The Minimum Bid Price Requirement In Nasdaq Listing Rule
1
2
发达发达
liked
$Draganfly (DPRO.US)$ You know i love my some big ole bottoms! Hehehe! Well this was a big ole bottom today before a little bounce! It just R/S the other day! It just released some good news on a new drone! Cool! Hehehe! Also at the AU defense Conference again tomorrow! So you this is a big ole bottom i likes lots! Hehehe
5
4
发达发达
liked and commented on
发达发达
commented on
$Kiora Pharmaceuticals (KPRX.US)$ 4: Statement of changes in beneficial ownership of securities-Director Shapiro Aron bought 3K shares at 3.60 PS
SEC· 41 mins ago
SEC· 41 mins ago
3
发达发达
liked and commented on
$BIO-key International (BKYI.US)$ Lotsa R in the 3 / 3.40 range
2
6
发达发达
liked and commented on
$Iterum Therapeutics (ITRM.US)$ watch this for catalyst.
1
3
发达发达
liked
$Quoin Pharmaceuticals (QNRX.US)$ form 4 consider as bullish? retail buyers are weird
3
1